| 000 | 01628 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518092712.0 | ||
| 264 | 0 | _c20210104 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1879-0720 | ||
| 024 | 7 |
_a10.1016/j.ejps.2020.105315 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNøhr-Nielsen, Asbjørn | |
| 245 | 0 | 0 |
_aPharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _cMay 2020 |
||
| 300 |
_a105315 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDocetaxel _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 700 | 1 | _aBagger, Sofie Otzen | |
| 700 | 1 | _aBrünner, Nils | |
| 700 | 1 | _aStenvang, Jan | |
| 700 | 1 | _aLund, Trine Meldgaard | |
| 773 | 0 |
_tEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _gvol. 148 _gp. 105315 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejps.2020.105315 _zAvailable from publisher's website |
| 999 |
_c30769838 _d30769838 |
||